The pharmaceutical giant, Takeda's President has claimed a dramatic annual salary that exceeds 23 billion yen. This casts light on the increasing executive compensation trends within Japanese corporations, sparking a public debate over fairness and the wealth gap. The exact payment breakdown and justification behind this high remuneration package is yet unknown.

In Japan, high executive compensation often draws public scrutiny and stimulates debates over income disparity, especially in large corporations like Takeda. This news will likely fuel such debates, since Japanese society is generally characterized by modest pay scales and high income inequality is not well-received.

In the US and EU, executive compensation is also a heated topic, often criticized for contributing to wealth inequality. However, compared to Japan, higher executive compensations are more commonly accepted, given the notion that such a high payout attracts top talent.